Natco Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE987B01026
  • NSEID: NATCOPHARM
  • BSEID: 524816
INR
819.25
-20.65 (-2.46%)
BSENSE

Feb 13

BSE+NSE Vol: 5.34 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
647.30
1,363.00
1,328.90
1,221.00
474.80
1,371.10
1,362.60
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
647.30
1,363.00
1,328.90
1,221.00
474.80
1,371.10
1,362.60
Raw Material Cost
135.20
174.90
180.60
169.00
72.70
143.20
151.30
Purchase of Finished goods
55.80
72.60
37.30
40.80
39.10
53.70
32.50
(Increase) / Decrease In Stocks
-57.90
-77.80
15.10
39.40
-29.00
-19.30
-3.60
Employee Cost
159.40
200.30
169.00
159.40
141.60
151.50
142.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
196.10
413.80
355.90
264.30
211.60
237.70
235.60
Total Expenditure (Excl Depreciation)
488.60
783.80
757.90
672.90
436.00
566.80
557.80
Operating Profit (PBDIT) excl Other Income
158.70
579.20
571.00
548.10
38.80
804.30
804.80
Other Income
58.10
100.00
61.70
66.30
176.30
63.80
48.10
Operating Profit (PBDIT)
216.80
679.20
632.70
614.40
215.10
868.10
852.90
Interest
9.50
13.10
3.20
10.20
4.40
4.10
5.20
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
207.30
666.10
629.50
604.20
210.70
864.00
847.70
Depreciation
46.20
52.40
57.60
98.30
47.00
45.80
44.10
Profit Before Tax
161.10
613.70
571.90
505.90
163.70
818.20
803.60
Tax
20.70
95.80
91.60
99.90
31.30
141.70
135.10
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
140.40
517.90
480.30
406.00
132.40
676.50
668.50
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
140.40
517.90
480.30
406.00
132.40
676.50
668.50
Share in Profit of Associates
10.90
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.20
-0.50
-0.40
-0.60
-0.60
-0.80
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
151.50
518.40
480.70
406.60
133.00
677.30
668.50
Equity Capital
35.80
35.80
35.80
35.80
35.80
35.80
35.80
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
8.46
28.96
26.85
22.72
7.43
37.84
37.35
Diluted Earnings per share
8.46
28.94
26.84
22.7
7.43
37.81
37.32
Operating Profit Margin (Excl OI)
24.52%
42.49%
42.97%
44.89%
8.17%
58.66%
59.06%
Gross Profit Margin
32.03%
48.87%
47.37%
49.48%
44.38%
63.02%
62.21%
PAT Margin
21.69%
38.0%
36.14%
33.25%
27.89%
49.34%
49.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is -52.51% vs 2.57% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is -70.78% vs 7.84% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -72.60% vs 1.44% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -27.48% vs 309.37% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of Natco Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
647.30
1,876.31
-1,229.01
-65.50%
Other Operating Income
0.00
0.00
0.00
Total Operating income
647.30
1,876.31
-1,229.01
-65.50%
Raw Material Cost
135.20
448.73
-313.53
-69.87%
Purchase of Finished goods
55.80
143.11
-87.31
-61.01%
(Increase) / Decrease In Stocks
-57.90
-62.87
4.97
7.91%
Employee Cost
159.40
432.71
-273.31
-63.16%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
196.10
621.13
-425.03
-68.43%
Total Expenditure (Excl Depreciation)
488.60
1,582.81
-1,094.21
-69.13%
Operating Profit (PBDIT) excl Other Income
158.70
293.50
-134.80
-45.93%
Other Income
58.10
15.50
42.60
274.84%
Operating Profit (PBDIT)
216.80
309.00
-92.20
-29.84%
Interest
9.50
23.31
-13.81
-59.24%
Exceptional Items
0.00
-42.23
42.23
100.00%
Gross Profit (PBDT)
207.30
243.46
-36.16
-14.85%
Depreciation
46.20
80.12
-33.92
-42.34%
Profit Before Tax
161.10
161.50
-0.40
-0.25%
Tax
20.70
29.55
-8.85
-29.95%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
140.40
133.79
6.61
4.94%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
140.40
133.79
6.61
4.94%
Share in Profit of Associates
10.90
-1.84
12.74
692.39%
Minority Interest
-0.20
-1.02
0.82
80.39%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
151.50
132.97
18.53
13.94%
Equity Capital
35.80
39.31
-3.51
-8.93%
Face Value
2.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
8.46
6.77
1.69
24.96%
Diluted Earnings per share
8.46
6.76
1.70
25.15%
Operating Profit Margin (Excl OI)
24.52%
15.64%
0.00
8.88%
Gross Profit Margin
32.03%
12.98%
0.00
19.05%
PAT Margin
21.69%
7.03%
0.00
14.66%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 647.30 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -52.51% vs 2.57% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 36.33% vs -37.41% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 151.50 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -70.78% vs 7.84% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 13.91% vs -37.47% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 158.70 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -72.60% vs 1.44% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 309.02% vs -85.53% in Dec 2024

Quarterly - Interest
Interest 9.50 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -27.48% vs 309.37% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 115.91% vs -4.35% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 24.52%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024